Summit Therapeutics
SMMT
$3.86
Share price
8.73%
Change (1 day)
192.42%
Change (1 year)
Categories
Summit Therapeutics (SMMT) Fails to deliver data
Key failure to deliver metrics for Summit Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.11 M
- Last 3 months FTD volume: $1.57 M
- Last year FTD volume: $9.72 M
Failures to deliver for Summit Therapeutics (SMMT) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Summit Therapeutics (SMMT) - since 2020
Volume in USD (price x number of shares), data since 2020Summit Therapeutics (SMMT) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.54 M | -93.28% |
| 2023 | $22.98 M | 51.4% |
| 2022 | $15.17 M | 108.24% |
| 2021 | $7.28 M | 443.49% |
| 2020 | $1.34 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $6.44 M | $36.3 M | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.1 M | $0.98 M | 🇺🇸 USA |
 Coherus BioSciences
CHRS | $3.85 M | $16.48 M | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | $0.21 B | 🇺🇸 USA |